Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rita Kazlauskas

Pediatrics Massillon, OH Medical Doctor

NPI 1841277670 CMS profile 356313

7452 Fulton Dr Nw, Ste. B, Massillon, OH 44646

Open in the dashboard

General payments

$4,604

309 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rita Kazlauskas of Massillon, OH is reported in the CMS Open Payments database as having received $4,604 across 309 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $362 21
2024 General $1,046 51
2023 General $722 41
2022 General $831 70
2021 General $609 56
2020 General $658 45
2019 General $376 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rita Kazlauskas
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Rita Kazlauskas were reported at $362. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Rita Kazlauskas Pediatrics median Middle half National median
2019 $376 $86 $31–$183 $163
2020 $658 $49 $22–$110 $114
2021 $609 $68 $27–$158 $132
2022 $831 $77 $30–$173 $149
2023 $722 $88 $33–$190 $160
2024 $1,046 $94 $34–$206 $164
2025 $362 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $821 43 payments
  2. Ironshore Pharmaceuticals Inc. $654 40 payments
  3. Tris Pharma Inc $582 50 payments
  4. Neos Therapeutics, LP $499 58 payments
  5. Sanofi Pasteur Inc. $373 15 payments
  6. Cranial Technologies, Inc $296 21 payments
  7. Merck Sharp & Dohme Corporation $188 14 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $170 11 payments
  9. GlaxoSmithKline, LLC. $168 6 payments
  10. Adlon Therapeutics L.P. $116 9 payments
  11. Other $736 42 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,598 308 payments
  2. Education $6 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $821 43 payments
  2. JORNAY PM Central Nervous System Stimulant $340 18 payments
  3. COTEMPLA XR-ODT $330 36 payments
  4. Adzenys XR-ODT $329 43 payments
  5. Doc Band $296 21 payments
  6. JORNAY PM Central Nervous Stimulant ADHD $266 19 payments
  7. BEYFORTUS $231 7 payments
  8. GARDASIL 9 $176 13 payments
  9. BEXSERO $168 6 payments
  10. VYVANSE $164 10 payments
  11. Other $2,941 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

309 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record